Business Wire

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

Share

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021911702/en/

Photo credit: IFF

This collaboration brings together two industry leaders with a shared vision: to develop high-performance, sustainable solutions that meet evolving consumer and market demands. By combining advanced chemical capabilities and expertise in biotechnology and protein engineering from IFF and BASF, the partnership aims to deliver breakthrough solutions at scale that enhance cleaning performance, improve personal care formulations, reduce environmental impact, and support the transition to a more sustainable future.

“We are very excited about the collaboration with BASF to jointly unlock new potential in enzyme and polymer technologies,” said Erik Fyrwald, CEO of IFF. “Our partnership enables us to develop market-driven solutions that create sustainable value for both the industry and the environment.”

“This partnership marks a strategically significant step for both companies,” said Michael Heinz, member of the board of executive directors at BASF. “By combining our research and development expertise, we are creating the foundation to bring large-scale innovative solutions to market faster for our customers.”

The joint effort will focus on innovative enzyme systems and biobased polymers, enabling customers to achieve superior performance while reducing resource consumption. Both companies will maintain independent operations and competitive positioning, while leveraging complementary strengths to accelerate innovation and expand choices for customers worldwide.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws. These statements relate to future events or performance and often include words such as “plan”, “expect,” “anticipate,” “intend,” “believe,” “will,” “may,” and similar expressions. Actual results may differ materially due to risks and uncertainties. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update them except as required by law.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

About BASF
At BASF2, we create chemistry for a sustainable future. Our ambition: We want to be the preferred chemical company to enable our customers’ green transformation. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises, as core businesses, the segments Chemicals, Materials, Industrial Solutions, and Nutrition & Care; our standalone businesses are bundled in the segments Surface Technologies and Agricultural Solutions. BASF generated sales of €65.3 billion in 2024. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at www.basf.com.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251021911702/en/

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share21.10.2025 15:41:00 EEST | Press release

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3 billion.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021765122/en/ Under the terms of the agreement, Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash plus a non-tradable contingent value right (CVR) to receive up to $3 per share in two payments of up to $1.50 each, for total consideration of up to $79 per share in cash. The non-tradable CVR would be issued to Hologic stockholders at closing and paid, in whole or in part, following achievement of certain global revenue goals for Hologic’s Breast Health business in fiscal years 2026 and 2027. The aggregate purchase price represents a premium of approximately 46% to Hologic’s cl

Tosi nimittää Jussi Postin talouspäälliköksi21.10.2025 15:00:00 EEST | Tiedote

Kyberfyysisten järjestelmien johtava toimittaja Tosi ilmoitti, että Jussi Posti aloittaa välittömästi yhtiön talouspäällikkönä. Posti ottaa vastuun Tosin kansainvälisestä taloushallinnosta ja strategisesta suunnittelusta, kun yhtiö jatkaa nopeaa kasvuaan uudelleenbrändäyksen ja tilaussopimusten 70 prosentin kasvun myötä. "Jussilla on ainutlaatuista kokemusta Fortune 500 -yhtiöiden talousjohtamisesta ja yrittäjämäisestä ajattelusta, mikä tekee hänestä ihanteellisen valinnan johtamaan Tosia seuraavassa kasvuvaiheessa", kertoo Sakari Suhonen, Tosin Yhdysvaltain toimitusjohtaja. "Hänen laajalla kokemuksellaan on ratkaiseva merkitys, kun uudistamme tapaa, jolla organisaatiot yhdistävät, suojaavat ja hallitsevat kriittisiä infrastruktuurejaan." Posti siirtyy Tosille toimittuaan lähes viiden vuoden ajan Microsoft Suomen talouspäällikkönä. Aiemmin hän on toiminut talouspäällikkönä Schneider Electricillä Suomessa ja Baltiassa sekä perustanut talousalan konsultointiyrityksen, jonka asiakkaita ov

ExaGrid Named Finalist for the MSP Channel Awards 202521.10.2025 15:00:00 EEST | Press release

ExaGrid®, the industry’s only Tiered Backup Storage solution with AI-Powered Retention Time-Lock (RTL) that includes a non-network-facing tier (tiered air gap), Auto Detect & Guard, delayed deletes and immutability for ransomware recovery, today announced that it has been nominated in six categories for the 1st annual MSP Channel Awards, which celebrates innovation across the IT Channel. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021571422/en/ The new MSP Channel Awards build on the legacy of the former SDC Awards to better reflect today's fast-moving IT landscape. As managed services reshape how technology is delivered – from digital transformation and cybersecurity to cloud, data, and automation – these awards recognize the companies, partnerships, and individuals making a real impact across the channel. Voting to determine the winner in each category is underway now and closes on November 7, 2025. Winners of the MS

Axelera Announces Europa AIPU, Setting New Industry Benchmark for AI Accelerator Performance, Power Efficiency and Affordability21.10.2025 15:00:00 EEST | Press release

Axelera AI, the leading provider of purpose-built AI hardware acceleration technology, today announced Europa™, an AI processor unit (AIPU) that sets a new performance/price standard for multi-user generative AI and computer vision applications. Europa’s combination of processing power, energy and thermal efficiency, compact packaging, and multiple form factor options make it ideal for compute-intensive, multi-modal AI inference applications from the edge to enterprise servers. Designed to be cost effective and accessible, Europa enables any organization to unlock the power of cutting-edge AI applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021493990/en/ Europa™ AIPU Next Gen Architecture for Real World AI Processing Power The Europa AIPU features eight second-generation AI cores, each incorporating Axelera’s advanced Digital In-Memory Compute (D‑IMC) technology and large vector engines, delivering up to 629 T

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital21.10.2025 15:00:00 EEST | Press release

Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today announced a majority investment by Curewell Capital (“Curewell”), a Los Angeles-based private equity firm focused on building industry-leading healthcare companies. Hui-Yin “Harry” Li, Ph.D., Founder and CEO of WPT, will retain a significant ownership stake and will continue to lead the business alongside the management team. The partnership with Curewell will provide significant growth capital to expand WPT’s manufacturing capacity and further scale its end-to-end capabilities in producing a full range of small molecule API in the U.S. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021135557/en/ Founded in 2003, WPT has built extensive expertise across hundreds of novel drug substance programs, spanning complex synthesis, med

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye